Eldad Melamed

Tel Aviv Univ, Tel Aviv-Yafo, Tel Aviv District, Israel 
"Eldad Melamed"
Mean distance: 14.64 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Petrou P, Gothelf Y, Argov Z, et al. (2016) Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials. Jama Neurology. 1-8
Lev N, Barhum Y, Ben-Zur T, et al. (2015) A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2. Plos One. 10: e0127549
Lev N, Barhum Y, Ben-Zur T, et al. (2015) A DJ-1 based peptide attenuates dopaminergic degeneration in mice models of Parkinson's disease via enhancing Nrf2 Plos One. 10
Lamm O, Ganz J, Melamed E, et al. (2014) Harnessing neurogenesis for the possible treatment of Parkinson's disease. The Journal of Comparative Neurology. 522: 2817-30
Petrou P, Argov A, Lennon VA, et al. (2014) Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy. Muscle & Nerve. 49: 455-7
de Munter JP, Melamed E, Wolters ECh. (2014) Stem cell grafting in parkinsonism--why, how and when. Parkinsonism & Related Disorders. 20: S150-3
Benninger F, Khlebtovsky A, Roditi Y, et al. (2014) Beneficial effect of levodopa therapy on stooped posture in Parkinson's disease Gait and Posture
Melamed E. (2013) The G2019S LRRK2 mutation: another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1912-4
Greenbaum L, Lorberboym M, Melamed E, et al. (2013) Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease. Frontiers in Neuroscience. 7: 52
Lev N, Barhum Y, Ben-Zur T, et al. (2013) Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity. Journal of Molecular Neuroscience : Mn. 50: 542-50
See more...